1.Targeting therapy of SLE associated thrombocytopenia with labeled antibody in vitro
Zhenyu JIANG ; Lili YU ; Mengyuan CAO ; Cheng YAO
Journal of Jilin University(Medicine Edition) 2006;0(04):-
Objective To discuss the feasibility and effect of labeled antibody on targeting therapy of systemic lupus erythematosus(SLE) associated thrombocytopenia.Methods MTX-IVIG conjugate was prepared by indirect and direct cross linking,and the binding ability of it to Fc fragment was detected by indirect immunofluor-escence.The killing activity of the conjugate was detected by MTT method using murine macrophage with Fc receptor and strain U937 of human monocytic leukemia cell as targets.Results Conjugation showed stronger cytotoxicity upon target cells than free MTX,and it showed less cytotoxic effect on Fc receptor negative cells compared with the positive ones.IVIG-HSA-MTX restrained the phagocyte of macrophage.The killing effect of IVIG-HSA-MTX was significantly stronger than that of IVIG-MTX.Conclusion The conjugation can show a highly specific cytotoxicity upon mononuclear-macrophage in vitro.
2.Neuroprotection of Dexmedetomidine against Cerebral Ischemia-Reperfusion Injury in Rats: Involved in Inhibition of NF-κB and Inflammation Response.
Lijun WANG ; Haiyan LIU ; Ligong ZHANG ; Gongming WANG ; Mengyuan ZHANG ; Yonghui YU
Biomolecules & Therapeutics 2017;25(4):383-389
Dexmedetomidine is an α2-adrenergic receptor agonist that exhibits a protective effect on ischemia-reperfusion injury of the heart, kidney, and other organs. In the present study, we examined the neuroprotective action and potential mechanisms of dexmedetomidine against ischemia-reperfusion induced cerebral injury. Transient focal cerebral ischemia-reperfusion injury was induced in Sprague-Dawley rats by middle cerebral artery occlusion. After the ischemic insult, animals then received intravenous dexmedetomidine of 1 μg/kg load dose, followed by 0.05 μg/kg/min infusion for 2 h. After 24 h of reperfusion, neurological function, brain edema, and the morphology of the hippocampal CA1 region were evaluated. The levels and mRNA expressions of interleukin-1β, interleukin-6 and tumor nevrosis factor-α as well as the protein expression of inducible nitric oxide synthase, cyclooxygenase-2, nuclear factor-κBp65, inhibitor of κBα and phosphorylated of κBα in hippocampus were assessed. We found that dexmedetomidine reduced focal cerebral ischemia-reperfusion injury in rats by inhibiting the expression and release of inflammatory cytokines and mediators. Inhibition of the nuclear factor-κB pathway may be a mechanism underlying the neuroprotective action of dexmedetomidine against focal cerebral I/R injury.
Animals
;
Brain Edema
;
CA1 Region, Hippocampal
;
Cyclooxygenase 2
;
Cytokines
;
Dexmedetomidine*
;
Heart
;
Hippocampus
;
Infarction, Middle Cerebral Artery
;
Inflammation*
;
Interleukin-6
;
Kidney
;
Neuroprotection*
;
Nitric Oxide Synthase Type II
;
Rats*
;
Rats, Sprague-Dawley
;
Reperfusion
;
Reperfusion Injury*
;
RNA, Messenger
3.Neuroprotection of Dexmedetomidine against Cerebral Ischemia-Reperfusion Injury in Rats: Involved in Inhibition of NF-κB and Inflammation Response.
Lijun WANG ; Haiyan LIU ; Ligong ZHANG ; Gongming WANG ; Mengyuan ZHANG ; Yonghui YU
Biomolecules & Therapeutics 2017;25(4):383-389
Dexmedetomidine is an α2-adrenergic receptor agonist that exhibits a protective effect on ischemia-reperfusion injury of the heart, kidney, and other organs. In the present study, we examined the neuroprotective action and potential mechanisms of dexmedetomidine against ischemia-reperfusion induced cerebral injury. Transient focal cerebral ischemia-reperfusion injury was induced in Sprague-Dawley rats by middle cerebral artery occlusion. After the ischemic insult, animals then received intravenous dexmedetomidine of 1 μg/kg load dose, followed by 0.05 μg/kg/min infusion for 2 h. After 24 h of reperfusion, neurological function, brain edema, and the morphology of the hippocampal CA1 region were evaluated. The levels and mRNA expressions of interleukin-1β, interleukin-6 and tumor nevrosis factor-α as well as the protein expression of inducible nitric oxide synthase, cyclooxygenase-2, nuclear factor-κBp65, inhibitor of κBα and phosphorylated of κBα in hippocampus were assessed. We found that dexmedetomidine reduced focal cerebral ischemia-reperfusion injury in rats by inhibiting the expression and release of inflammatory cytokines and mediators. Inhibition of the nuclear factor-κB pathway may be a mechanism underlying the neuroprotective action of dexmedetomidine against focal cerebral I/R injury.
Animals
;
Brain Edema
;
CA1 Region, Hippocampal
;
Cyclooxygenase 2
;
Cytokines
;
Dexmedetomidine*
;
Heart
;
Hippocampus
;
Infarction, Middle Cerebral Artery
;
Inflammation*
;
Interleukin-6
;
Kidney
;
Neuroprotection*
;
Nitric Oxide Synthase Type II
;
Rats*
;
Rats, Sprague-Dawley
;
Reperfusion
;
Reperfusion Injury*
;
RNA, Messenger
4.Recent advances in objective evaluation of the aging jawline
Mengyuan ZHANG ; Nanze YU ; Xiao LONG
Chinese Journal of Plastic Surgery 2024;40(10):1041-1046
Improvement of the jawline contour is a key focus in lower face and neck rejuvenation treatments. Achieving a well-defined, smooth jawline is a shared goal for both patients and plastic surgeons. This article reviews recent research on age-related changes of the jawline and evaluation method, offering valuable references for jawline rejuvenation treatments.The jawline's unique anatomical position, coupled with age-related changes, involves dynamic alterations in bone, soft tissue, and skin across multiple layers, making rejuvenation of this area a complex and challenging task. In recent years, advances in imaging technologies such as two-dimensional photography, three-dimensional stereophotogrammetry, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and micro-CT have expanded the understanding of jawline anatomy and provided precise tools for analysis and evaluation.
5.Recent advances in objective evaluation of the aging jawline
Mengyuan ZHANG ; Nanze YU ; Xiao LONG
Chinese Journal of Plastic Surgery 2024;40(10):1041-1046
Improvement of the jawline contour is a key focus in lower face and neck rejuvenation treatments. Achieving a well-defined, smooth jawline is a shared goal for both patients and plastic surgeons. This article reviews recent research on age-related changes of the jawline and evaluation method, offering valuable references for jawline rejuvenation treatments.The jawline's unique anatomical position, coupled with age-related changes, involves dynamic alterations in bone, soft tissue, and skin across multiple layers, making rejuvenation of this area a complex and challenging task. In recent years, advances in imaging technologies such as two-dimensional photography, three-dimensional stereophotogrammetry, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and micro-CT have expanded the understanding of jawline anatomy and provided precise tools for analysis and evaluation.
6.Construction of Raji-Luc CD19 KO Lymphoma Cell Line Using CRISPR/Cas9 Technology
Jingjing LIU ; Xiuying LIU ; Yaru FENG ; Yichao FENG ; Mengyuan YU ; Jianxun WANG
Journal of Modern Laboratory Medicine 2024;39(1):10-15,99
Objective To construct Raji-Luc lymphoma cells with CD19 knockout using CRISPR/Cas9 technology and preliminarily validate their immune escape ability.Methods PB-CRISPR-CD19 small guide RNA(sgRNA)plasmids was constructed,the optimal sgRNA sequence was screened,and Raji-Luc cells with pCAG-PBase,PB-CD19 sgRNA,and PB-CRISPR-Cas9 were co-transfected.Stable knockout monoclonal cell lines were screened by flow sorting and limit dilution method and the knockout effect was verified through gene sequence testing.The expression of luciferase on the surface of the cell line was detected by microplate reader,CD19 CAR-T and CD38 CAR-T previously constructed in the laboratory were used as effector cells,and the immune escape ability of Raji-Luc CD19 KO cell line was verified by universal luciferase chemiluminescence method.Results The transfection efficiency of Raji-Luc CD19 KO cells prepared by electro transfection was high,and the knockout efficiency of the two monoclonal cells was more than 99%.There was no significant difference in luciferase expression compared to the original Raji-Luc cells,and CD19 CAR-T cells could not be activated to the kill them.Conclusion Successfully constructed Raji-Luc CD19 KO lymphoma cell line.
7.Effects of empowerment education model in patients with coronary heart disease after PCI
Mingxing XU ; Xiaoxiang YU ; Weiling HAO ; Mengyuan ZHAO ; Meng YUAN ; Shunna GAN ; Ying XU ; Jiayu HAN ; Jing YU ; Minrou XU ; Yanfang ZHAO
Chinese Journal of Modern Nursing 2022;28(19):2625-2629
Objective:To explore the effect of empowerment education in patients with coronary heart disease after percutaneous coronary intervention (PCI) .Methods:From June 2020 to July 2021, convenience sampling was used to select 90 patients with coronary heart disease who received PCI in the Department of Cardiology of Qinhuai Medical District, Eastern Theater Command General Hospital as the research object. The 45 patients admitted from June to December 2020 were set as the control group, and the 45 patients admitted from January to July 2021 were set as the observation group. The control group received routine health education, and the observation group was given empowerment education on this basis. The physical activity level and aerobic exercise endurance of the two groups of patients were compared.Results:Repeated measures analysis of variance showed that there were between-group, time and interaction effects in the 6-minute walking distance between the two groups before intervention, one month and three months after intervention, and the differences were statistically significant ( P<0.05) . The physical activity levels of patients in the observation group were higher than those in the control group after one and three months of intervention, and the differences were statistically significant ( P<0.05) . Conclusions:Empowerment education can improve physical activity level and aerobic exercise endurance in patients with coronary heart disease after PCI.
8.Potential therapeutic effects and applications of Eucommiae Folium in secondary hypertension
Mengyuan LI ; Yanchao ZHENG ; Sha DENG ; Tian YU ; Yucong MA ; Jiaming GE ; Jiarong LI ; Xiankuan LI ; Lin MA
Journal of Pharmaceutical Analysis 2022;12(5):711-718
Eucommiae Folium(EF),a traditional Chinese medicine,has been used to treat secondary hypertension,including renal hypertension and salt-sensitive hypertension,as well as hypertension caused by thoracic aortic endothelial dysfunction,a high-fat diet,and oxidized low-density lipoprotein.The antihyperten-sive components of EF are divided into four categories:flavonoids,iridoids,lignans,and phenyl-propanoids,such as chlorogenic acid,geniposide acid and pinoresinol diglucoside.EF regulates the occurrence and development of hypertension by regulating biological processes,such as inhibiting inflammation,regulating the nitric oxide synthase pathway,reducing oxidative stress levels,regulating endothelial vasoactive factors,and lowering blood pressure.However,its molecular antihypertensive mechanisms are still unclear and require further investigation.In this review,by consulting the relevant literature on the antihypertensive effects of EF and using network pharmacology,we summarized the active ingredients and pharmacological mechanisms of EF in the treatment of hypertension to clarify how EF is associated with secondary hypertension,the related components,and underlying mechanisms.The results of the network pharmacology analysis indicated that EF treats hypertension through a multi-component,multi-target and multi-pathway mechanism.In particular,we discussed the role of EF tar-gets in the treatment of hypertension,including epithelial sodium channel,heat shock protein70,rho-associated protein kinase 1,catalase,and superoxide dismutase.The relevant signal transduction path-ways,the ras homolog family member A(RhoA)/Rho-associated protein kinase(ROCK)and nicotinamide adenine dinucleotide phosphate(NADPH)oxidase/eNOS/NO/Ca2+pathways,are also discussed.
9.Smart bandage for chronic wound management
Mengyuan ZHANG ; Zhaojian WANG ; Jiuzuo HUANG ; Nanze YU ; Xiao LONG
Chinese Journal of Plastic Surgery 2024;40(10):1041-1045
The management of chronic wounds presents significant challenges, characterized by a low rate of healing and substantial impairment of patients’ quality of life, while also exerting a considerable strain on healthcare resources. Wound healing is a multifactorial and dynamic process, necessitating close monitoring of wound changes and timely, appropriate interventions. Smart bandage/dressing, an innovative approach born from interdisciplinary research, offers a new generation of wound care. It enables dynamic quantitative monitoring of wound conditions, facilitates transdermal drug release and physical mode therapeutics, and adjusts interventions in real time based on monitoring outcomes. In comparison to traditional wound dressings, smart bandages exhibit attributes such as real-time responsiveness, precision, and convenience. They not only simplify wound management but also enhance patient comfort and compliance, showcasing potential as a safe and effective new treatment modality. Smart bandages hold promise for elevating the efficiency of managing chronic wounds, reducing morbidity rates, alleviating the burden of disease, and ultimately improving patients’ quality of life. This paper summarized the recent research progress of smart bandages and provide insights into novel wound care strategies.
10.Recent advances in objective evaluation of the aging jawline
Mengyuan ZHANG ; Nanze YU ; Xiao LONG
Chinese Journal of Plastic Surgery 2024;40(11):1249-1254
Improvement of the jawline contour is a critical focus in lower face and neck rejuvenation treatments. Achieving a well-defined, smooth jawline is a shared goal between patients and plastic surgeons. This article reviewed recent research on age-related changes of the jawline and evaluation method, offering valuable references for jawline rejuvenation treatments.The jawline’s unique anatomical position, coupled with age-related changes, involves dynamic alterations in bone, soft tissue, and skin across multiple layers, making rejuvenation of this area a complex and challenging task. In recent years, advances in imaging technologies such as two-dimensional photography, three-dimensional stereophotogrammetry, computed tomography, magnetic resonance imaging, ultrasound, and micro-CT have expanded the understanding of jawline anatomy and provided precise tools for analysis and evaluation.